Drug discovery is one of humanity’s most powerful yet painfully slow processes.
It takes over 10 years and billions of dollars to move from an idea to a drug molecule.
Pauling.AI changes that.
We built the first fully autonomous AI Chemist, a multi-agent system that automates the entire early discovery process, from target definition to optimized molecule generation.
You tell our AI what you’re looking for a specific protein, mechanism, or property and it designs, tests, and refines molecular candidates in days, not months.
Pauling.AI combines generative chemistry, molecular simulation, and machine reasoning to achieve what used to require entire discovery teams.
Our agents reason about molecular structure, run virtual assays, predict ADMET properties, and collaborate to propose the most promising drug candidates autonomously.
We believe the future of drug discovery isn’t about scaling human effort. It’s about automating it intelligently.
With Pauling.AI, biotech startups and pharma companies can explore more targets, fail faster, and innovate without expanding their R&D teams.
From idea to molecule in days.
Welcome to the era of the AI Chemist.
Comments (0)
No comments yet. Be the first to share your thoughts!